Rothschild Investment LLC’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.45K Buy
923
+322
+54% +$1.94K ﹤0.01% 2346
2026
Q1
$3.7K Buy
601
+393
+189% +$3.26K ﹤0.01% 2225
2025
Q4
$2.17K Buy
208
+18
+9% +$181 ﹤0.01% 2323
2025
Q3
$1.71K Buy
190
+175
+1,167% +$1.54K ﹤0.01% 2326
2025
Q2
$195 Sell
15
-55
-79% -$827 ﹤0.01% 2933
2025
Q1
$1.77K Buy
70
+40
+133% +$1.19K ﹤0.01% 1968
2024
Q4
$1.03K Sell
30
-5
-14% -$225 ﹤0.01% 2202
2024
Q3
$1.73K Buy
35
+20
+133% +$1.02K ﹤0.01% 1805
2024
Q2
$903 Buy
15
+10
+200% +$571 ﹤0.01% 1713
2024
Q1
$258 Buy
+5
New +$245 ﹤0.01% 1634

Other funds holding RXST

Rothschild Investment LLC's RXST Position: Q2 2026 in Review

Rothschild Investment LLC increased its RxSight (RXST) stake by 54% in Q2 2026, buying an estimated $1.94K and bringing the position to 923 shares worth $4.45K. The position accounts for ﹤0.01% of the portfolio, ranked #2346.

Rothschild Investment LLC first reported a position in RXST in Q1 2024 and has held it in 10 quarters since. 38 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Rothschild Investment LLC held 923 shares of RxSight worth $4.45K as of Q2 2026.
  • Rothschild Investment LLC bought 322 RxSight shares in Q2 2026, an estimated $1.94K.
  • RxSight made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2346 holding.
  • Rothschild Investment LLC first reported a position in RxSight in Q1 2024 and has held it in 10 quarters since.
  • 38 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.